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Cellular discrimination using in vitro Raman micro
spectroscopy: the role of the nucleolus†
Z. Farhane,*a F. Bonnier,b A. Casey,a A. Maguire,a L. O’Neilla and H. J. Byrnea
Raman micro spectroscopy has attracted considerable attention over the last few years to explore its
possible clinical applications as a non-invasive powerful label-free in vitro screening tool in cancer diag-
nosis and monitoring, subcellular analysis of biochemical processes, drug uptake, mode of action and
mechanisms of interaction as well as toxicity of, for example, chemotherapeutic agents. However, in
order to evaluate accurately the potential of Raman micro spectroscopy for such applications it is essen-
tial to optimise measurement and data processing protocols associated with subcellular analysis. To this
end, in vitro differentiation of cell lines is a basic proof of concept for the potential of the technique, and
although many studies have indicated successful differentiation based on Raman micro spectroscopy, it is
important, as the measurement and processing techniques are improved, to establish the biochemical
and subcellular basis of that discrimination. In this study, Raman micro spectroscopy is used to compare
and differentiate normal and cancer cells from human lung origin, A549 adenocarcinoma cell line, Calu-1
epidermoid non-small-cell and BEAS-2B normal immortalized bronchial epithelium cell line. Spectra
were taken from the three subcellular compartments, cytoplasm, nucleus and nucleolus and Principal
Components Analysis was used to compare the spectral profiles between the cell lines and, coupled to
Linear Discriminant Analysis, to explore the optimum sensitivity and specificity of discrimination. To
support the analysis, Raman micro spectroscopy was coupled with Flow Cytometry, Confocal Laser Scan-
ning Microscopy and Atomic Force Microscopy. While all subcellular regions can be employed to differen-
tiate the normal and cancer cell lines, optimum discrimination sensitivity and specificity is achieved using
the spectra from the nucleolar region alone. Notably, only the nucleolar spectral profiles differentiate the
two cancer cell lines. The results point to the importance of the nucleolar regions in diagnostic appli-
cations of Raman microscopy as well as further applications in subcellular analysis of cytological
processes.
1. Introduction
Recent decades have seen a notable expansion in exploration
of biomedical applications of Raman micro spectroscopy,1–3
due to the fact that it is a powerful, rapid and non-destructive
label-free technique for studying biological systems such as
tissue and cells.4,5
Raman micro spectroscopy can detect chemical, biological
and physical changes of biomolecules, and the specific infor-
mation contained in the cellular Raman spectrum provides a
molecular fingerprint of the sample of interest, which allows
Raman micro spectroscopy to differentiate between normal
and abnormal cells and tissues, indicating possible appli-
cations for example in cancer research.5,6 Indeed, Raman
micro spectroscopy has been shown to provide high specificity
and sensitivity, even for pre-cancer detection,7–10 and is non-
invasive and potentially automatable, thus avoiding the dis-
advantages of many biomedical techniques used to identify
and sort cancerous cells from normal ones, which exhibit low
specificity and are destructive or perturb the cellular
biology.11–13
As an optical microscopic technique, Raman micro spec-
troscopy also has the potential to probe the molecular struc-
ture on a cellular and subcellular level.14,15 In comparison to
Infrared absorption spectroscopy; Raman micro spectroscopy
offers the possibility to study biological matrices in an
aqueous environment due to the weak contribution from
water.16,17 Thus, the potential applications extend beyond
disease diagnostics to the label free in vitro screening of cyto-
logical processes, such as drug or nanoparticle uptake and
mechanisms of interaction, and toxicology.16,18–20 There has
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been a wide range of studies to date demonstrating the poten-
tial of Raman micro spectroscopy to map live and fixed cells
with subcellular resolution,21–25 profile the distribution
of anticancer agents26–30 and nanoparticles in cells16,31,32
and monitor subcellular processes33 and toxicological
responses.34–37
Fundamental to the development of applications of Raman
micro spectroscopy for disease diagnostics as well as analysis
of cytological processes is an understanding of the variability
of the spectral signatures across the subcellular environment,
their potential for differentiation of cell phenotype or diseased
state, and their sensitivity to external perturbation, such as
viral infection, radiation damage, or chemical stress due to, for
example, toxic or chemotherapeutic agents. It is clear that the
signatures for the cytoplasm, nucleus and nucleoli are distinct
and differentiable,38 but it is not clear which region has the
best diagnostic potential or sensitivity to external insult. The
current study examines the subcellular basis of differentiation
of human cell lines in vitro, both normal and cancerous, using
Raman micro spectroscopy.
Numerous studies over the last few years have investigated
the capability of Raman micro spectroscopy to differentiate
between cancerous cell lines; Crow et al.39 used human pros-
tate cancer cell lines, Pijanka et al. investigated lung cancer
cell lines,40 and Chan et al. explored neoplastic hematopoietic
cells,11 while Krishna et al. were interested in mixed cell popu-
lations of human promyelocytic leukemia and breast cancer.41
All those studies demonstrated that Raman micro spectro-
scopy, coupled with multivariate statistics, is able to dis-
tinguish between different cell lines with a high specificity and
sensitivity. However, the basis of the differentiation was not
elucidated in terms of the subcellular regions.
In this study, Raman profiles of three cell lines from same
anatomical origin, the human lung, were compared and ana-
lysed. The first part is the investigation of the differentiation of
a normal human bronchial epithelium cell line, BEAS-2B,
from the adenocarcinoma human alveolar basal epithelial cell
line, A549, and the non-small-cell lung cancer cell line Calu-1.
Thereafter, the two cancer cell lines are compared to each
other, using Raman micro spectroscopy. The morphological
and topographical characteristics of the two human lung
cancer cell lines A549 and Calu-1, using Flow Cytometry,
CLSM and AFM were also analysed and correlated to their
Raman spectroscopic features.
In all cases, spectral profiles of the cytoplasm, nucleus and
nucleoli were independently acquired and analysed, and the
study highlights the importance of the nucleoli in potential
diagnostic and bioanalytical applications.
2. Materials and methods
2.1. Materials
A549 human lung adenocarcinoma cells with the alveolar type
II phenotype, and BEAS-2B normal human bronchial epi-
thelium (ATCC® CRL-9609™), virus transformed, infected with
a replication-defective SV40/Adenovirus 12 hybrid and cloned,
were all obtained from ATTC (Manassas, VA, USA). Calu-
1 human lung epidermoid cells were obtained from the Euro-
pean Collection of Cell Cultures.
SYTO® Green Fluorescent Nucleic Acid Stains and Wheat
Germ Agglutinin conjugates (WGA), a cell membrane glyco-
conjugates binder, purchased from BioSciences (Ireland,
suppliers for Life Technologies), were employed to image the
nuclear compartment and cytoplasmic membrane of cells
using Confocal Laser Scanning Microscopy.
2.2. Cell culture
A549 and BEAS-2B cells were cultured in DMEM (with 2 mM
L-glutamine) and Calu-1 in RPMI, all with 10% foetal bovine
serum (FBS) at 37 °C in an humidified atmosphere containing
5% CO2 and cells were split every two days to maintain ∼60%
confluence.
2.3. Sample preparation and measurement protocols
2.3.1. Raman micro spectroscopy. Cells ∼5000 were
seeded and incubated on CaF2 windows (Crystan Ltd, UK) for
48 h in order to achieve a final number of approximately 104
cells. Medium was removed and samples were rinsed twice
with sterile PBS then fixed using formalin (4%, 15 mn) and
spectra were recorded after air drying in ambient atmosphere.
A Horiba Jobin–Yvon LabRAM HR800 spectrometer with a
785 nm, 300 mW diode laser as source, Peltier cooled 16-bit
CCD, 300 lines per mm grating and 100 μm confocal hole, was
used for this work. Spectra were acquired from the three cell
locations: cytoplasm, nuclear and nucleolar in the range from
400 cm−1 to 1800 cm−1 with an ×100 objective (LCPlanN,
Olympus) for 30 s two times, to finally produce a data set of 30
points per cell location for each cell line, over a total of 90
different cells.
2.3.2. Confocal laser scanning fluorescence microscopy
(CLSM). Samples were prepared on uncoated glass bottom
Petri dishes (MatTek Corporation, USA). Approximately 104
Cells were allowed to attach for two hours, then covered with
cell culture medium. After incubation, the medium was
removed and samples were rinsed twice with sterile PBS and
fixed in formalin (4%, 15 mn).
After fixation, samples were washed with Hank’s balanced
salt solution (HBSS) and WGA (7.5 µL of WGA per 1 mL HBSS)
was first added and cells were incubated for 20 min and
washed with HBSS. Sytox® green nucleic acid stain (2 µL per
1 mL of HBSS) was thereafter added, cells were incubated for
30 min and washed with HBSS then imaged in HBSS.
Confocal Laser Scanning microscopic images were recorded
using an inverted Zeiss LSM 510 confocal laser scanning
microscope equipped with a ×60 oil immersion objective. Exci-
tation wavelengths used were 488 nm for Sytox® green nucleic
acid stain (emission wavelength 523 nm) and 633/647 nm exci-
tation/emission for WGA.
2.3.3. Flow cytometry. Cells were cultured in T75 flasks
over 48 h and then trypsinised and centrifuged in 10 mL fresh
medium at 4 °C and 1000 rpm for 5 min. After this, the cells
Analyst Paper
This journal is © The Royal Society of Chemistry 2015 Analyst, 2015, 140, 5908–5919 | 5909
Pu
bl
ish
ed
 o
n 
20
 Ju
ly
 2
01
5.
 D
ow
nl
oa
de
d 
by
 D
ub
lin
 In
sti
tu
te
 o
f T
ec
hn
ol
og
y 
on
 1
0/
02
/2
01
6 
15
:0
1:
31
. 
View Article Online
were re-suspended with 5 mL PBS and only 2 mL was used for
analysis. Samples were prepared in parallel and the two cell
lines were analysed separately. A total number of 2 × 104 cells
was analysed for each sample. The experiments were con-
ducted in triplicate (three independent experiments).
Flow cytometry analysis was performed using a BD Bio-
sciences Accuri C6 Flow Cytometer (Becton Dickinson, Oxford,
UK) without any dyes.
2.3.4. Atomic force microscopy (AFM). The air dried
samples on CaF2 substrates were profiled using a MFP-3D BIO
AFM (Asylum Research). The cantilevers used were Olympus
silicon AC240. Tips were 160 nm long and had a typical reso-
nant frequency of 70 kHz. The AFM was operated in AC mode
in order to minimize tip/sample interaction. Typical free air
amplitudes were ∼200 mV and a high amplitude set-point rela-
tive to the set-point was maintained to minimize sample
damage. The images obtained, from 5 to 10 cells per cell line,
contained 1024 pixels per scan line and only one representa-
tive image of typical cell for each cell line is shown.
2.4. Data analysis
Raman spectra pre-processing and analysis were performed in
Matlab 2013 using algorithms developed in house.
Prior to analysis, spectra were smoothed (Savitsky–Golay
filter 5th order, 7 points), baseline corrected, substrate back-
ground subtracted, using a polynomial method home develo-
ped, and vector normalised.
After pre-processing, PCA (principal components analysis)
and PCA-Linear Discriminants Analysis (PCA-LDA), powerful
approaches commonly used for the analysis of large spectral
data sets, were employed as supervised multivariate analysis
tools to differentiate the data recorded from different subcellu-
lar localisations and cell lines. PCA allows the reduction of the
number of variables in a multidimensional dataset, the order
of the PCs denoting their importance in the dataset where PC1
describes the highest amount of variation.18,20 While PCA
identifies differences between the data sets, LDA maximizes
these differences so as to group similar spectral sets. PCA per-
forms a feature reduction of the data and LDA classifies the
data into one of two or more classes. Thus, if a group of
spectra have a similar correlation to the shape defined by PC1
and that defined by PC2; they are classified as same class.
PCA was performed on each of the datasets independently
(nucleoli, nucleus, and cytoplasm). LDA was then performed
on each of the datasets scores independently and a 10-fold
cross validation was performed to produce confusion
matrices.42,43 LDA accuracy was calculated using a 10-fold
cross validation on increasing numbers of latent variables (PC
scores) for the classification of all cancer types and normal
cells. The classification which resulted in the maximum accu-
racy while keeping the number of latent variables to a
minimum was chosen for all successive models. In the case of
the classification of all cancer cells and normal one, from a
plot of accuracy as a function of increasing number of latent
variables, the maximum accuracy was found when 4 principal
components were used in the classification. Further addition
of principal components only increased the complexity of the
model without further improving the performance.
The Accuri Flow cytometry software was used for the initial
analysis of flow cytometry samples, but the Beckman Coulter
Summit software and the FCS Express Research Edition have
been used for the reanalysis of the samples. The QC control of
the instrument was performed using Spherotech 6 and 8 peak
beads.
3. Results and discussion
3.1. Raman micro spectroscopy
Raman spectra were taken from the three cell compartment for
all cell lines and Fig. 1 shows the average spectra corres-
ponding to each cell region for Calu-1 cells. Visibly, it can be
seen that the mean spectra of the nucleolar, nuclear and cyto-
plasmic regions are somewhat different, and discriminating
peaks (indicated by highlighted regions in Fig. 1) at, for
example, 1578, 1095, 830 and 795 cm−1 can be allocated to
nucleic acids which correspond respectively to vibrations of
the DNA bases adenine and guanine, DNA PO2
− symmetric
stretching, ribose phosphate and DNA backbone O–P–O
stretching,44,45 while others at 1300 (CH deformation) and
717 cm−1 (CN + (CH3)3 stretching) are associated with lipid
components of the cell membrane, which are also observable
in subsequent spectra of the nuclear and nucleolar regions,
although more prominently in the spectra of the cytoplasmic
region. The DNA bands at 1095 cm−1 and 830 cm−1 indicate
that the DNA is in B form and one at 813 cm−1 corresponds to
DNA A form.17
Similar profiles were obtained for the subcellular analysis
of A549 cells.
For a more detailed understanding of the differences in
spectral profiles of the subcellular regions, a multivariate ana-
lysis is more informative, and therefore, PCA was employed to
analyse and compare the spectral profiles of the subcellular
regions as well as the differences between cancer and normal
cell lines. Figures representing the differentiation of the
Fig. 1 Mean spectra of nucleolus (A), nucleus (B) and cytoplasm (C) of
Calu-1 cell line. Highlighted regions indicate discriminatory features.
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spectra by PCA according to the corresponding PC loadings
were plotted and, for clarity, in all PCA figures, the loadings
are off set, the dashed horizontal line in all cases indicating
zero loading.
As an illustration of the analysis technique used through-
out, Fig. 2A shows the PCA scatter plot of the cytoplasmic,
nuclear and nucleolar spectra of the Calu-1 cell line, along
with the corresponding loadings of PC1 and PC2. PC1 clearly
differentiates between the cytoplasmic and integrated nuclear
regions (nuclear and nucleolar) and, according to the corres-
ponding loading (loading 1), the most visible discriminant fea-
tures derive from DNA, 795 cm−1 and 1095 cm−1, related to
DNA form and DNA PO2
− symmetric stretching, and lipids at
717 cm−1 (CN + (CH3)3 stretching), 1300 (CH2 stretching) and
1440 cm−1 (CH stretching). The differentiation of the subcellu-
lar regions according to PC1 is not unexpected, due to the
significant biochemical differences between the combined
nuclear and cytoplasmic regions which are similar for all cell
lines.
Although some degree of discrimination of the nuclear and
nucleolar regions according to PC2 is evident in Fig. 2A, a
better visualisation of this is achieved by a direct pairwise PCA
of the two datasets, as shown in Fig. 2B. PC1 now clearly differ-
entiates the nucleolar and nuclear regions. It exhibits discrimi-
nating negative peaks related to nucleoli at 782 and 1336 cm−1
(Uracil, Cytosine and Thymine) corresponding to RNA,46
1242 cm−1 (Amide II), 1480 cm−1 (Guanine, Adenine) and
1578 cm−1 (proteins) due to the contribution of surrounded
membrane, as well as positives ones at 728 (Adenine),
830 cm−1 (O–P–O asymmetric stretching) and 1095 cm−1 (DNA
PO2
− symmetric stretching), corresponding to the nuclear
region, which is the primary location of DNA, while the nucleo-
lar regions contain RNA and a small quantities of DNA.4,38
Similar differentiation can be achieved for the subcellular
regions of A549 cells (data not shown).
In a similar fashion, PCA was employed to compare the
spectral profiles of the normal lung human cell line BEAS-2B
to the two lung cancer cell lines A549 and Calu-1.
The PCA scatter plot of Fig. 3A compares the three subcellu-
lar regions of all three lung cell lines. PC1 largely differentiates
between the cytoplasmic regions and the integrated nuclear
and nucleolar regions of the cells, and the corresponding
loading exhibit features related to nucleic acid (DNA and RNA)
and lipids, similar to the loading of PC1 in Fig. 2A.
Accounting for 21% of the explained variance, PC2 indi-
cates a clear differentiation between the normal cell line and
the two cancerous ones. Although the loading of PC2 rep-
resents differentiating features of all three subcellular regions,
identifiable features include negative peaks at 669 (Thymine
and Guanine), 728 (Adenine), 1095 cm−1 (DNA PO2-symmetric
Fig. 2 A. PCA scatter plot of nucleolar, nuclear and cytoplasmic regions of Calu-1 cells, with corresponding loadings of PC1 and PC2. B. PCA of
nucleolar and nuclear regions of Calu-1 cells and corresponding loading of PC1. Cytoplasm, Nucleus, ● Nucleolus.
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stretching) and ones at 1005 (Phenylalanine), 1320 (Guanine),
1440 (Guanine and Adenine), and 1665 cm−1 (Amide I), associ-
ated with the cancer cell lines. Positive peaks corresponding to
lipids at 760 and 820 (tryptophan ring), 1115 (C–C stretching),
1250 and 1420 cm−1 (lipids CvC and C–H vibration) are
associated with the normal cell line. A similar scatterplot and
loadings profile, with separation between integrated nuclear
region and cytoplasmic area according to PC1 and differen-
tiation of normal and cancer cell line according to PC2 is
observable when cell lines were analysed pairwise, A549 versus
BEAS-2B and Calu-1 against BEAS-2B (Fig. S1, ESI†).
The PCA discriminating features between normal and
cancer cells correspond to DNA and proteins for cancer cell
lines and lipids for the normal one, which is consistent with
the fact that cancerous cells have a more active metabolism
and exhibits more proteins and more DNA than normal cells
but present less cytoplasm and therefore lipids are positive dis-
criminating features for normal cells.
The differentiation of the cell lines is more evident when
the subcellular regions are analysed independently using PCA,
as shown in Fig. 3B. The normal and cancerous cell lines are
now largely discriminated by PC1 and almost the same discri-
minating features can be found in the loadings of PC1 for the
nucleolar and nuclear regions, while additional peaks in the
loading of PC1 for the cytoplasm of the normal versus cancer-
ous cells are observed at 760 and 820 (tryptophan ring) and
1250 (Amide III), related to normal cells and ones at 717 (CN +
(CH3)3 stretching), 1400 (CH deformation) and 1578 cm
−1
(protein) 1661 cm−1 (lipids CvC stretching) related to cancer-
ous cell lines.4,17,30,47
Thus using PCA allows a separation between normal and
cancerous cell lines. Notably, however, no differentiation of
the cancerous cell lines is evident. To investigate this further,
the cancer cell lines were compared to each other and spectra
from the nucleolus, nucleus and cytoplasm were similarly
analysed.
Fig. 3 PCA of nucleolar, nuclear and cytoplasmic regions of A. A549, Calu-1 and BEAS-2B with corresponding loadings of PC1 and PC2. B. PCA of
each cell localisation for A549, Calu-1 and BEAS-2B and the corresponding loadings of PC1. Cytoplasm Nucleus Nucleolus ● A549 cell line;
Cytoplasm Nucleus Nucleolus ▼ Calu-1 cell line; Cytoplasm Nucleus Nucleolus ■ BEAS-2B cell line.
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As shown in Fig. 4A, a scatter plot of the combined PCA of
the nucleolar, nuclear and cytoplasmic regions of the A549,
Calu-1 cancer cell lines, there is no clear separation between
the two cells. As before, PC1 differentiates between the cyto-
plasmic and combined subcellular regions, but, in contrast to
the comparison of the normal and cancerous cell line, there is
no clear differentiation between the two cell lines. Indeed, PC1
discriminates between the cytoplasm and the combined
Fig. 4 PCA scatterplots and corresponding loadings of PC1 and PC2 of A549 and Calu-1 cells: A. nucleolus, nucleus and cytoplasm B. nucleolus,
C. nucleus D. cytoplasm. Cytoplasm Nucleus Nucleolus ● A549 cell line; Cytoplasm Nucleus Nucleolus ▼ Calu-1 cell line.
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nuclear region, for both cell lines and the corresponding
loading exhibits features corresponding to lipids, 717 and
873 cm−1 (CN+ (CH3)3, 1270 and 1303 cm
−1 (C–H vibrations)
and 1450 (CH2 deformation) and ones related to DNA at 784
(Cytosine and Thymine), 1095 (DNA PO2− symmetric stretch-
ing) and 1578 cm−1 (Guanine, Adenine). PC2 partially discrimi-
nates the nucleolar and nuclear regions and exhibits
discriminating negative peaks for the nucleolar region at 784
and 1336 cm−1 (Uracil, Cytosine and Thymine) corresponding
to RNA, 1242 cm−1 (Amide II), 1480 cm−1 and 1578 cm−1
(Guanine, Adenine), as well as positives ones at 728 (Adenine),
830 cm−1 (O–P–O asymmetric stretching) and 1095 cm−1 (DNA
PO2
− symmetric stretching), corresponding to the nuclear
region.4,38
Therefore it appears that Raman micro spectroscopy is
unable to differentiate between cancerous cells, although it is
able to distinguish the subcellular regions for all cell lines.
Nevertheless, previous studies, have demonstrated the
ability of Raman micro spectroscopy to distinguish between
different cancer cell lines.8,11,28,40,48,49 To explore the apparent
discrepancy in results, the individual subcellular regions were
further analysed (Fig. 4B–D).
Results shows no indication of discrimination between the
two lung cancerous cells for the nuclear and cytoplasmic areas
(Fig. 4C and D) although there is some degree of differen-
tiation according to PC1 (35% of variation) for the nucleolar
regions of A549 and Calu-1 (Fig. 4B). Discriminant features of
the loading of PC1 include negative peaks at 1270 (RNA Uracil
and cytosine ring stretching), 1320 and 1450 (CH2 de-
formation) and 1661 cm−1 (Lipids CvC stretching). The same
features are found to be higher in the mean spectra of nucleo-
lar A549 compared to Calu-1 (Fig. 5), indicating that there
are more lipids in the former. Also prominent in the loading
of PC1 are also two strong positive peaks at 784 cm−1
(Uracil, Cytosine and Thymine) and 811 cm−1 (RNA O–P–O
phosphodiester bond) as well as ones at 1240 (Amide III),
1480 and 1578 cm−1 (Guanine, Adenine), which indicate that
there is a stronger RNA contribution in Calu-1 cells than A549.
This can be clearly seen in the mean nucleolar spectra
in Fig. 5.
Moreover, according to the mean spectra, it seems that the
most notable differences in nuclear and nucleolar regions
between A549 and Calu-1 corresponds to the features at
813 cm−1 (DNA A form) and at 830 cm−1 (DNA B form). The
ratio between to the two peaks (enlargement Fig. 5) is inverted
which signifies that there is more DNA B form in A549 than in
Calu-1 and vice versa.
To support Raman micro spectroscopy observations, Con-
focal Laser Scanning Microscopy, Flow Cytometry and Atomic
Force Microscopy were in their turn employed to compare the
two human lung cancer cell lines.
3.2. Confocal laser scanning fluorescence microscopy
(CLSM)
CLSM was employed in order to identify the morphological
characteristics of the two cell lines, A549 and Calu-1. As shown
in Fig. 6, before and after nucleic and cytoplasmic staining,
the two cell lines present a different shape and size, as well as
numbers of nucleoli, which are clearly resolved within the
nucleus and have diameters ∼2–4 μm. Indeed, WGA, a cyto-
plasmic membrane stain which delimits the cytoplasmic mem-
brane, highlights the shape of cells and shows that Calu-1 are
bigger and longer than A549 cells, while Sytox® green, a
specific nuclear dye which has a high affinity for DNA, shows
that Calu-1 cells present a higher density of nucleoli and a
larger nuclear area than A549 cells.
Fig. 5 Mean spectra of A. nucleolus of A549 (green) and Calu-1 (black),
B. nucleus of A549 (red) and Calu-1 (magenta) and C. cytoplasm of A549
(blue) and Calu-1 (cyan).
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3.3. Flow cytometry
As shown in Fig. 7, the flow cytometry 2D scatter plots are
different from one cell line to another, indicating that Calu-1
cells are more spread and bigger in size than A549. This is con-
firmed in the histograms; Calu-1 (red) and A549 (green) show
a difference in cell surface and size (FSC forward scatter) and
cell granularity and internal environment (SSC side scattering)
between the two cell lines, confirming that Calu-1 cells present
larger size and dispersive granularity of the nucleus, which
explains the most significant percentage of cellular side scat-
tering,50 than A549, consistent with the confocal microscopy
results.
3.4. AFM
AFM shows that both cell lines have different topography.
Indeed, according to Fig. 8 A549 cells are higher and more
convex than Calu-1 (Height 1.4 µm for A549 compared to
1.2 µm for Calu-1). Additionally, it can be seen from the struc-
ture of the height profiles that Calu-1 cells have more surface
granularity, consistent with larger number of nucleoli, which
confirms the CLSM and flow cytometry results.
According to Flow Cytometry (SCC maximum 500 000 for
A549 and 1 000 000 for Calu-1) and AFM (Fig. 7 and 8), A549
cells are thicker than Calu-1 but present fewer and smaller
nucleoli, which is confirmed by CLSM. Nucleoli size for both
cell lines is by the order of 2–4 µm, larger than the Raman
laser spot (1 µm) and, according to Raman micro spectro-
scopy; RNA is more prominent in Calu-1 nucleoli than those of
A549.
3.5. PCA-LDA
Thus, CLSM, Flow Cytometry and AFM show that A549 and
Calu-1 cells are different in size, morphology and topography.
Raman micro spectroscopy was unable to differentiate
between them with high sensitivity according to the biochemi-
cal fingerprint of the cytoplasmic or nuclear regions alone.
However, differentiation of cell lines is achievable according to
the spectroscopic signature of the nucleoli.
Fig. 6 Confocal fluorescence images of A. A549 and B. Calu-1 stained with Sytox® green nucleic acid stain and WGA.
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Fig. 8 AFM images of A. A549 and B. Calu-1: 3D image, height scan and topographical profile generated for height scan; respectively.
Fig. 7 Flow cytometry 2D scatter plots (FSC vs. SSC) with debris excluded and histograms ((FSC vs. cell number) and (SCC vs. cell number)) for both
cancer cell lines A549 (green) and Calu-1 (red).
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Nucleoli are non-membrane-bound nuclear compartments,
well described and analysed in details since the last millen-
nium.51,52 They are responsible for ribosome biogenesis and
diverse cellular functions and processes such as cell cycle
control, cellular stress response, nuclear export and sequestra-
tion of key proteins regulators of cell-cycle activity and
response to apoptosis and early stage cellular response to toxic
such as chemotherapeutic drugs.30 The size, number and
organisation of nucleoli are cell-specific and nuclear proteins,
notably histone, play an important role in the nucleoli stability
and functions.53,54
The important role played by nucleoli and its cell specificity
explain the fact that it is spectroscopically the discriminant
factor between cancer cell lines. For confirmation, PCA was
coupled with LDA and confusion matrices were generated
using 4 principal components and, in the first instance,
nucleolar and nuclear areas were analysed in combination.
The results shown in Table 1A indicate a sensitivity and speci-
ficity of between 40 and 60% for the two cancerous cell lines
and 91.8% specificity and 93.2% specificity for the normal
cells, BEAS-2B, which confirms, along with the LDA plot in
Fig. 9, that poor discrimination between the cancerous cell
lines is achievable. To improve the specificity and sensitivity,
the nucleolar and nuclear regions were analysed separately.
Table 1 Confusion matrix table for A549, Calu-1 and BEAS-2B.
A. nucleolus + nucleus, B. nucleolus, C. nucleus and D. cytoplasm
A549 Calu-1 BEAS-2B
A.
A549 40 18 2
Calu-1 16 43 1
BEAS-2B 2 3 55
Sensitivity % 68.9 78.1 94.8
Specificity % 52.3 52.7 91.9
B.
A549 26 4 0
Calu-1 1 29 0
BEAS-2B 0 0 30
Sensitivity % 96.2 87.8 100
Specificity % 87.8 96.2 100
C.
A549 19 9 2
Calu-1 6 23 1
BEAS2B 1 4 25
Sensitivity % 73.1 63.8 89.2
Specificity % 67.6 70.8 84.3
D.
A549 23 7 0
Calu-1 14 16 0
BEAS-2B 4 1 25
Sensitivity % 56.1 66.6 100
Specificity % 63.1 61.1 83.3
Fig. 9 PCA – LDA of subcellular regions of A549, Calu-1, and BEAS-2B. A. nucleolar + nuclear, B. nucleolar, C. nuclear and D. cytoplasm.
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It is notable that in the confusion matrix of Table 1B, for
the nucleolar regions of BEAS-2B, the sensitivity and specificity
are 100% (separation is obvious in Fig. 9B). A clearly better
separation for the two cancerous cell lines is achievable for the
nucleolar region, and a similar amelioration can be observed
for the nuclear region (Table 1C), although the specificity and
sensitivity remains lower than that of the nucleolar region. Sig-
nificantly lower sensitivities and specificities were obtained for
the cytoplasmic regions of the cancer cell lines (Table 1D). The
results are supported by the PCA-LDA plot in Fig. 9.
In summary, Raman micro spectroscopy coupled with both
PCA and PCA-LDA highlights the critical importance of
nucleoli in determining the biochemical identity of the cell.
Recent studies using Raman micro spectroscopy to investigate
the nucleoli biochemical and molecular composition, and
differences in this nuclear compartment between normal and
cancer cell lines, highlighted the potential role of the nucleoli
in cell differentiation55,56 The current study confirms that this
nuclear organelle, in addition to its essential cellular function,
is also the primary source of the differentiating Raman spectro-
scopic fingerprint of the cell lines. Notably, the improved
differentiation of the cell lines based on the spectral profiles
of the nucleoli alone does not consider the additional discri-
minating factor of the number and or density of nucleoli in
the nucleus of different cell lines. In studies which compare
an integrated spectral analysis of the nucleus of the cell,34 this
factor will amplify the intrinsic biochemical differences of the
nucleoli of different cell lines. The study points towards the
importance of the nucleoli in the diagnostic potential of
Raman micro spectroscopy. The role of the nucleoli in the
early stage response of cells to chemotherapeutic agents has
also been demonstrated,27 indicating the sensitivity of the
spectral profile of this subcellular region to cytological
processes.
4. Conclusion
While this study confirms the ability of Raman micro spectro-
scopy to differentiate between normal and cancerous cell
lines in vitro, as well as between cancer cell-lines from the
same anatomical site, it clearly demonstrates that the discrimi-
nating potential varies depending on the subcellular region
analysed. As, typically, the sampled spot size in Raman micro
spectroscopy is less than the cell area, this has important
implications for optimisation of diagnostic potential in cyto-
pathology, but also for the sensitivity of analysis of cellular
processes such as the action of chemotherapeutic agents.
A comparison of normal and cancer cell lines indicates that
all subcellular regions are differentiable. However, the classifi-
cation sensitivities and specificities are lowest for the cyto-
plasmic regions. While somewhat improved classification is
achievable using the spectra of the integrated nuclear region,
classification based on the nucleolar regions alone is signifi-
cantly superior. Notably, in the detailed spectral analysis, the
cancer cell lines were only well differentiated on the basis of
the nucleolar regions.
The morphological analysis demonstrates that the cells
differ significantly in their nucleolar content, while the
spectroscopic study indicates significant differences in the
individual nucleolar biochemical content. The study demon-
strates the importance of the nucleoli in its contribution to the
diagnostic potential of Raman micro spectroscopy as well as
further applications in subcellular analysis of cytological
processes.
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